サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：単純ヘルペスウイルス治療市場-ウイルスタイプ別、薬剤タイプ別、投与部位別、投与経路別、流通チャネル別、世界予測、2023～2032年
市場調査レポート
商品コード
1399642

単純ヘルペスウイルス治療市場-ウイルスタイプ別、薬剤タイプ別、投与部位別、投与経路別、流通チャネル別、世界予測、2023～2032年

Herpes Simplex Virus Treatment Market - By Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir), Site (Oral, Genital), Route of Administration (Oral, Topical), Distribution Channel (Hospital, Retail), Global Forecast, 2023-2032

出版日
ページ情報
英文 220 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
単純ヘルペスウイルス治療市場-ウイルスタイプ別、薬剤タイプ別、投与部位別、投与経路別、流通チャネル別、世界予測、2023～2032年
出版日: 2023年11月23日
発行: Global Market Insights Inc.
ページ情報: 英文 220 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の単純ヘルペスウイルス治療市場は、治療アプローチの進歩、ヘルペス感染症に対する意識の高まり、単純ヘルペスウイルス2型（HSV-2）の有病率の上昇に後押しされ、2023年から2032年にかけて4％の成長率を記録すると予測されています。

2023年のWHOの報告によると、50歳以下の世界人口の約67％（37億人）が口唇ヘルペスの原因となる単純ヘルペスウイルス1型（HSV-1）に感染しています。15～49歳の推定13％（4億9,100万人）が単純ヘルペスウイルス2型（HSV-2）に感染しており、性器ヘルペスを引き起こしています。多くのHSV感染は無症状であるか、または認識されないです。一般の人々の意識が高まるにつれて、ヘルペスウイルスの性質、感染、と合併症の可能性についての知識が深まりつつあります。早期診断と適切な治療への注目は、高度な治療ソリューションへの需要に寄与しています。

世界の単純ヘルペスウイルス治療産業は、ウイルスタイプ、薬剤タイプ、投与部位、投与経路、流通チャネル、地域に基づいて分類されます。

HSV-2ウイルスタイプは、世界人口の間で有病率が上昇していることから、調査期間中に持続的な成長が見込まれています。HSV-2がもたらす特有の課題への対処に焦点を当てた研究開発活動が急増しており、このヘルペス株の独特な特徴に対応した特殊な治療オプションの必要性が強調されています。

バラシクロビル製剤は、ウイルスの複製を阻害することによりヘルペス感染症の治療に有効であるため、2032年まで安定した成長が見込まれています。アシクロビルのプロドラッグであるバラシクロビルは、バイオアベイラビリティを高め、抗ウイルス活性を長持ちさせ、感染を抑制します。さらに、この薬剤はHSV-1とHSV-2の両方に対して有効であるため、臨床医と患者の両方にとって好ましい選択肢となっています。

アジア太平洋の単純ヘルペスウイルス治療市場規模は、2023年から2032年にかけて急速な拡大が見込まれています。中国やインドのような国では、医療のインフラが著しく進歩しています。また、性感染症に対する意識が高まっており、効果的なヘルペス治療ソリューションの需要に寄与しています。この地域の好ましい医療政策は、今後数年間の業界力学を形成すると思われます。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 単純ヘルペスウイルス治療市場洞察

  • 業界情勢
  • 業界への影響要因
    • 促進要因
      • ヘルペス感染者の増加
      • 研究開発の増加
      • 政府の資金援助と認知度の向上
    • 業界の潜在的リスク・課題
      • 製品リコールの増加
      • ワクチンの入手不可能性
  • 成長可能性分析
  • COVID-19影響分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 主要市場参入企業の競合分析
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 単純ヘルペスウイルス治療市場推定・予測：ウイルスタイプ別

  • 主要動向：ウイルスタイプ別
  • 単純ヘルペスウイルス1型
  • 単純ヘルペスウイルス2型

第6章 単純ヘルペスウイルス治療市場、推定・予測：薬剤タイプ別、2018～2032年

  • 主要動向：薬剤タイプ別
  • アシクロビル
  • バラシクロビル
  • ファムシクロビル
  • その他の薬剤タイプ

第7章 単純ヘルペスウイルス治療市場推定・予測：投与部位別

  • 主要動向：投与部位別
  • 経口
  • 性器
  • その他の部位

第8章 単純ヘルペスウイルス治療市場推定・予測：投与経路別

  • 主要動向：投与経路別
  • 経口
  • 注射
  • 局所

第9章 単純ヘルペスウイルス治療市場推定・予測：流通チャネル別

  • 主要動向：流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 単純ヘルペスウイルス治療市場推定・予測：地域別

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他の中東とアフリカ

第11章 企業プロファイル

  • GlaxoSmithKline plc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • Glenmark Pharmaceuticals Limited
  • Amneal Pharmaceuticals LLC
  • Novartis AG
  • Abbott Laboratories
  • Fresenius Kabi AG
  • Emcure Pharmaceuticals Ltd
  • Viatris Inc.
図表

Data Tables

  • TABLE 1 Market revenue, by virus type (2022)
  • TABLE 2 Market revenue, by drug type (2022)
  • TABLE 3 Market revenue, by site (2022)
  • TABLE 4 Market revenue, by route of administration (2022)
  • TABLE 5 Market revenue, by distribution channel (2022)
  • TABLE 6 Market share, by region (2022)
  • TABLE 7 Global herpes simplex virus treatment market size, by region, 2018 - 2022 (USD Million)
  • TABLE 8 Global herpes simplex virus treatment market size, by region, 2023 - 2032 (USD Million)
  • TABLE 9 Global herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 10 Global herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 11 Global herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 12 Global herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 13 Global herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 14 Global herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 15 Global herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 16 Global herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 17 Global herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 18 Global herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 19 Industry impact forces
  • TABLE 20 Herpes simplex virus-1 market, 2018 - 2022 (USD Million)
  • TABLE 21 Herpes simplex virus-1 market, 2023 - 2032 (USD Million)
  • TABLE 22 Herpes simplex virus-2 market, 2018 - 2022 (USD Million)
  • TABLE 23 Herpes simplex virus-2 market, 2023 - 2032 (USD Million)
  • TABLE 24 Acyclovir market, 2018 - 2022 (USD Million)
  • TABLE 25 Acyclovir market, 2023 - 2032 (USD Million)
  • TABLE 26 Valacyclovir market, 2018 - 2022 (USD Million)
  • TABLE 27 Valacyclovir market, 2023 - 2032 (USD Million)
  • TABLE 28 Famciclovir market, 2018 - 2022 (USD Million)
  • TABLE 29 Famciclovir market, 2023 - 2032 (USD Million)
  • TABLE 30 Other drug types market, 2018 - 2022 (USD Million)
  • TABLE 31 Other drug types market, 2023 - 2032 (USD Million)
  • TABLE 32 Oral market, 2018 - 2022 (USD Million)
  • TABLE 33 Oral market, 2023 - 2032 (USD Million)
  • TABLE 34 Genital market, 2018 - 2022 (USD Million)
  • TABLE 35 Genital market, 2023 - 2032 (USD Million)
  • TABLE 36 Other sites market, 2018 - 2022 (USD Million)
  • TABLE 37 Other sites market, 2023 - 2032 (USD Million)
  • TABLE 38 Oral market, 2018 - 2022 (USD Million)
  • TABLE 39 Oral market, 2023 - 2032 (USD Million)
  • TABLE 40 Injectable market, 2018 - 2022 (USD Million)
  • TABLE 41 Injectable market, 2023 - 2032 (USD Million)
  • TABLE 42 Topical market, 2018 - 2022 (USD Million)
  • TABLE 43 Topical market, 2023 - 2032 (USD Million)
  • TABLE 44 Hospital pharmacy market, 2018 - 2022 (USD Million)
  • TABLE 45 Hospital pharmacy market, 2023 - 2032 (USD Million)
  • TABLE 46 Retail pharmacy market, 2018 - 2022 (USD Million)
  • TABLE 47 Retail pharmacy market, 2023 - 2032 (USD Million)
  • TABLE 48 Online pharmacy market, 2018 - 2022 (USD Million)
  • TABLE 49 Online pharmacy market, 2023 - 2032 (USD Million)
  • TABLE 50 North America herpes simplex virus treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 51 North America herpes simplex virus treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 52 North America herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 53 North America herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 54 North America herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 55 North America herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 56 North America herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 57 North America herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 58 North America herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 59 North America herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 60 North America herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 61 North America herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 62 U.S. herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 63 U.S. herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 64 U.S. herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 65 U.S. herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 66 U.S. herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 67 U.S. herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 68 U.S. herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 69 U.S. herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 70 U.S. herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 71 U.S. herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 72 Canada herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 73 Canada herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 74 Canada herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 75 Canada herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 76 Canada herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 77 Canada herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 78 Canada herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 79 Canada herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 80 Canada herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 81 Canada herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 82 Europe herpes simplex virus treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 83 Europe herpes simplex virus treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 84 Europe herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 85 Europe herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 86 Europe herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 87 Europe herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 88 Europe herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 89 Europe herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 90 Europe herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 91 Europe herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 92 Europe herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 93 Europe herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 94 Germany herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 95 Germany herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 96 Germany herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 97 Germany herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 98 Germany herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 99 Germany herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 100 Germany herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 101 Germany herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 102 Germany herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 103 Germany herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 104 UK herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 105 UK herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 106 UK herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 107 UK herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 108 UK herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 109 UK herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 110 UK herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 111 UK herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 112 UK herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 113 UK herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 114 France herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 115 France herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 116 France herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 117 France herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 118 France herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 119 France herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 120 France herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 121 France herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 122 France herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 123 France herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 124 Spain herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 125 Spain herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 126 Spain herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 127 Spain herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million
  • TABLE 128 Spain herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 129 Spain herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 130 Spain herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 131 Spain herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 132 Spain herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 133 Spain herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 134 Italy herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 135 Italy herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 136 Italy herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 137 Italy herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 138 Italy herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 139 Italy herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 140 Italy herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 141 Italy herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 142 Italy herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 143 Italy herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 144 Rest of Europe herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 145 Rest of Europe herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 146 Rest of Europe herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 147 Rest of Europe herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 148 Rest of Europe herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 149 Rest of Europe herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 150 Rest of Europe herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 151 Rest of Europe herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 152 Rest of Europe herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 153 Rest of Europe herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 154 Asia Pacific herpes simplex virus treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 155 Asia Pacific herpes simplex virus treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 156 Asia Pacific herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 157 Asia Pacific herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 158 Asia Pacific herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 159 Asia Pacific herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 160 Asia Pacific herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 161 Asia Pacific herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 162 Asia Pacific herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 163 Asia Pacific herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 164 Asia Pacific herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 165 Asia Pacific herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 166 China herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 167 China herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 168 China herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 169 China herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 170 China herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 171 China herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 172 China herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 173 China herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 174 China herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 175 China herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 176 Japan herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 177 Japan herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 178 Japan herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 179 Japan herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 180 Japan herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 181 Japan herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 182 Japan herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 183 Japan herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 184 Japan herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 185 Japan herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 186 India herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 187 India herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 188 India herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 189 India herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 190 India herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 191 India herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 192 India herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 193 India herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 194 India herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 195 India herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 196 Australia herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 197 Australia herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 198 Australia herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 199 Australia herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 200 Australia herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 201 Australia herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 202 Australia herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 203 Australia herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 204 Australia herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 205 Rest of Asia Pacific herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 206 Rest of Asia Pacific herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 207 Rest of Asia Pacific herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 208 Rest of Asia Pacific herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 209 Rest of Asia Pacific herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 210 Rest of Asia Pacific herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 211 Rest of Asia Pacific herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 212 Rest of Asia Pacific herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 213 Rest of Asia Pacific herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 214 Rest of Asia Pacific herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 215 Latin America herpes simplex virus treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 216 Latin America herpes simplex virus treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 217 Latin America herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 218 Latin America herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 219 Latin America herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 220 Latin America herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 221 Latin America herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 222 Latin America herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 223 Latin America herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 224 Latin America herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 225 Latin America herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 226 Latin America herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 227 Brazil herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 228 Brazil herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 229 Brazil herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 230 Brazil herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 231 Brazil herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 232 Brazil herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 233 Brazil herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 234 Brazil herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 235 Brazil herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 236 Brazil herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 237 Mexico herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 238 Mexico herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 239 Mexico herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 240 Mexico herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 241 Mexico herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 242 Mexico herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 243 Mexico herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 244 Mexico herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 245 Mexico herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 246 Mexico herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 247 Rest of Latin America herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 248 Rest of Latin America herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 249 Rest of Latin America herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 250 Rest of Latin America herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 251 Rest of Latin America herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 252 Rest of Latin America herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 253 Rest of Latin America herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 254 Rest of Latin America herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 255 Rest of Latin America herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 256 Rest of Latin America herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 257 Middle East & Africa herpes simplex virus treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 258 Middle East & Africa herpes simplex virus treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 259 Middle East & Africa herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 260 Middle East & Africa herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 261 Middle East & Africa herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 262 Middle East & Africa herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 263 Middle East & Africa herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 264 Middle East & Africa herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 265 Middle East & Africa herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 266 Middle East & Africa herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 267 Middle East & Africa herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 268 Middle East & Africa herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 269 South Africa herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 270 South Africa herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 271 South Africa herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 272 South Africa herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 273 South Africa herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 274 South Africa herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 275 South Africa herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 276 South Africa herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 277 South Africa herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 278 South Africa herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 279 Saudi Arabia herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 280 Saudi Arabia herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 281 Saudi Arabia herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 282 Saudi Arabia herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million
  • TABLE 283 Saudi Arabia herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 284 Saudi Arabia herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 285 Saudi Arabia herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 286 Saudi Arabia herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 287 Saudi Arabia herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 288 Saudi Arabia herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 289 Rest of Middle East & Africa herpes simplex virus treatment market size, by virus type, 2018 - 2022 (USD Million)
  • TABLE 290 Rest of Middle East & Africa herpes simplex virus treatment market size, by virus type, 2023 - 2032 (USD Million)
  • TABLE 291 Rest of Middle East & Africa herpes simplex virus treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 292 Rest of Middle East & Africa herpes simplex virus treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 293 Rest of Middle East & Africa herpes simplex virus treatment market size, by site, 2018 - 2022 (USD Million)
  • TABLE 294 Rest of Middle East & Africa herpes simplex virus treatment market size, by site, 2023 - 2032 (USD Million)
  • TABLE 295 Rest of Middle East & Africa herpes simplex virus treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 296 Rest of Middle East & Africa herpes simplex virus treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 297 Rest of Middle East & Africa herpes simplex virus treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 298 Rest of Middle East & Africa herpes simplex virus treatment market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Herpes simplex virus treatment market industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by virus type
  • FIG 8 Growth potential analysis, by drug type
  • FIG 9 Growth potential analysis, by site
  • FIG 10 Growth potential analysis, by route of administration
  • FIG 11 Growth potential analysis, by distribution channel
  • FIG 12 Porter's analysis
  • FIG 13 PESTEL analysis
  • FIG 14 Company matrix analysis, 2022
  • FIG 15 Competitive analysis of major market players
  • FIG 16 Competitive positioning matrix
  • FIG 17 Strategic dashboard, 2022
目次
Product Code: 7466

The global Herpes Simplex Virus (HSV) treatment market is expected to register a 4% growth rate during 2023-2032, propelled by advancements in therapeutic approaches, rising awareness about herpes infections, and a growing prevalence of Herpes Simplex Virus-2 (HSV-2).

As per a WHO report in 2023, about 67% of the global population aged below 50 years (3.7 billion) have herpes simplex virus type 1 (HSV-1), causing oral herpes. An estimated 13% of people aged 15-49 years (491 million) has herpes simplex virus type 2 (HSV-2), leading to genital herpes. Many HSV infections are asymptomatic or go unrecognized. As public awareness builds overtime, individuals are becoming more informed about the nature, transmission, and potential complications associated with herpes viruses. The focus on early diagnosis and appropriate treatments is contributing to the demand for advanced therapeutic solutions.

The global Herpes Simplex Virus (HSV) treatment industry is classified based on virus type, drug type, site, route of administration, distribution channel, and region.

The HSV-2 virus type segment is expected to witness sustained growth during the study period driven by its rising prevalence amongst the global population. There is a surge in R&D activities focused on addressing the specific challenges posed by HSV-2, emphasizing the need for specialized treatment options catering to the unique characteristics of this herpes strain.

The valacyclovir drug type segment is set for steady growth through 2032 owing to its efficacy in managing herpes infections by inhibiting viral replication. As a prodrug of acyclovir, valacyclovir enhances bioavailability and ensures prolonged antiviral activity, thereby curbing the infection. Moreover, the drug is effective against both HSV-1 and HSV-2, making it a preferred choice for clinicians and patients alike.

Asia Pacific Herpes Simplex Virus (HSV) treatment market size is anticipated to witness rapid expansion over 2023-2032, driven by a surge in the prevalence of herpes infections, necessitating increased attention to treatment and management strategies. Countries like China and India are experiencing notable advancements in healthcare infrastructure. Also, there is a growing awareness of sexually transmitted infections, contributing to the demand for effective herpes treatment solutions. The favourable healthcare policies in the region will shape the industry dynamics in the coming years.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Herpes simplex virus treatment industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Virus type trends
    • 2.1.4 Drug type trends
    • 2.1.5 Site trends
    • 2.1.6 Route of administration trends
    • 2.1.7 Distribution channel trends

Chapter 3 Herpes Simplex Virus Treatment Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of herpes infection
      • 3.2.1.2 Rising research and development
      • 3.2.1.3 Increasing government funding and awareness
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Increasing product recalls
      • 3.2.2.2 Unavailability of vaccines
  • 3.3 Growth potential analysis
    • 3.3.1 By virus type
    • 3.3.2 By drug type
    • 3.3.3 By site
    • 3.3.4 By route of administration
    • 3.3.5 By distribution channel
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic dashboard, 2022

Chapter 5 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Virus Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by virus type
  • 5.2 Herpes simplex virus 1
  • 5.3 Herpes simplex virus 2

Chapter 6 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Drug Type, 2018-2032 (USD Million)

  • 6.1 Key trends, by drug type
  • 6.2 Acyclovir
  • 6.3 Valacyclovir
  • 6.4 Famciclovir
  • 6.5 Other drug types

Chapter 7 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Site, 2018-2032 (USD Million)

  • 7.1 Key trends, by site
  • 7.2 Oral
  • 7.3 Genital
  • 7.4 Other sites

Chapter 8 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

  • 8.1 Key trends, by route of administration
  • 8.2 Oral
  • 8.3 Injectable
  • 8.4 Topical

Chapter 9 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)

  • 9.1 Key trends, by distribution channel
  • 9.2 Hospital pharmacy
  • 9.3 Retail pharmacy
  • 9.4 Online pharmacy

Chapter 10 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 10.1 Key trends, by region
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East & Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

  • 11.1 GlaxoSmithKline plc
  • 11.2 Pfizer Inc
  • 11.3 Teva Pharmaceutical Industries Ltd
  • 11.4 Glenmark Pharmaceuticals Limited
  • 11.5 Amneal Pharmaceuticals LLC
  • 11.6 Novartis AG
  • 11.7 Abbott Laboratories
  • 11.8 Fresenius Kabi AG
  • 11.9 Emcure Pharmaceuticals Ltd
  • 11.10 Viatris Inc.